Buscar en
Clínica e Investigación en Arteriosclerosis (English Edition)
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis (English Edition) Most often read
Journal Information

Most often read

301
“Methodological notes”: a new and important section in Clínica e Investigación en Arteriosclerosis
Josep Ribalta, Carlos Lahoz, Xavier Pintó
Clin Investig Arterioscler. 2023;35:243
301
Full text access
Open Article
146
Absence of the influence of the APOE gene on the incidence of type 2 diabetes mellitus in a cohort of workers: Effect of diet and shift work
Rocío Mateo-Gallego, Sofía Pérez-Calahorra, Ana M. Bea, Irene Gracia-Rubio, Carmen Rodrigo-Carbo, Belen Moreno-Franco, Fernando Civeira, Martín Laclaustra, Itziar Lamiquiz-Moneo
Clin Investig Arterioscler. 2023;35:226-35
146
124
Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV study
Elena M. Yubero-Serrano, Francisco M. Gutiérrez-Mariscal, Purificación Gómez-Luna, Juan F. Alcalá-Diaz, Pablo Pérez-Martinez, José López-Miranda
Clin Investig Arterioscler. 2023;35:105-14
124
73
Health-related lifestyle assessment among Spanish adults from 22 to 72 years
Pedro Luis Rodríguez García, Juan José Pérez Soto, Eliseo García Cantó, Marcos Meseguer Zafra, Raúl Salmerón Ríos, Pedro Juan Tárraga López
Clin Investig Arterioscler. 2023;35:12-20
73
Open Article
72
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor
Susana Martín-Vañó, Alejandra Miralles-Abella, Pascual Castaño, Gema Hurtado-Genovés, María Aguilar-Ballester, Andrea Herrero-Cervera, Angela Vinué, Sergio Martínez-Hervás, Herminia González-Navarro
Clin Investig Arterioscler. 2023;35:1-11
72
Open Article
60
Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer
María A. Zuriaga, José J. Fuster
Clin Investig Arterioscler. 2023;35:35-41
60
Open Article
46
Vascular smooth muscle cell aging: Insights from Hutchinson-Gilford progeria syndrome
Magda R. Hamczyk, Rosa M. Nevado
Clin Investig Arterioscler. 2023;35:42-51
46
Open Article
37
Eating frequency has an inverse correlation with adiposity measures and non-invasive arterial stiffness parameters in healthy adult people
Sajjad Arefinia, Lida Jarahi, Hamed Khedmatgozar, Saeed Eslami Hasan Abadi, Mohammad Reza Shadmand Foumani Moghadam, André Tchernof, Hosein Soleimaninia, Reza Rezvani
Clin Investig Arterioscler. 2023;35:21-31
37
Open Article
34
Arterial ageing and atherosclerotic risk: new perspectives
Vicente Lahera Juliá, Ana M. Lahera García
Clin Investig Arterioscler. 2023;35:32-4
34
Open Article
28
Prevalence rates of chronic kidney disease and its association with cardiometabolic factors and cardiovascular diseases. SIMETAP-CKD study
Antonio Ruiz-Garcia, Ezequiel Arranz-Martínez, Nerea Iturmendi-Martínez, Teresa Fernández-Vicente, Montserrat Rivera-Teijido, Juan Carlos García-Álvarez
Clin Investig Arterioscler. 2023;35:64-74
28
Open Article
28
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories
Teresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruiz, Manuel Rodríguez Piñero, José Francisco Valderrama Marcos, Antonio Pérez Pérez, Manuel Antonio Botana López, Ana Morais López, ... en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular
Clin Investig Arterioscler. 2023;35:91-100
28
Open Article
21
Geostatistical analysis from the clinical laboratory in cardiovascular prevention for primary care
Salomón Martín Pérez, Teresa Arrobas Velilla, Juan Fabiani de la Iglesia, Ignacio Vázquez Rico, Gema Varo Sánchez, Antonio León-Justel
Clin Investig Arterioscler. 2023;35:75-84
21
Open Article
14
Association of rs662799 and rs5070 genetic polymorphisms with hypertriglyceridemia and atherogenic dyslipidemia in pediatric patients in Southeast Mexico
Valeria Ovando Gómez, Soraya Amalí Zavaleta Muñiz, Héctor Ochoa-Díaz-López, José Armando Camilo Hernández Contreras, Cesar Antonio Irecta Nájera
Clin Investig Arterioscler. 2023;35:53-63
14
Open Article
12
Evolocumab como tratamiento de la dislipemia secundaria a lorlatinib
Laura Pérez Alonso, Raquel Cervera Calero, María Ángeles Campos Fernández de Sevilla, Miguel Ángel Moreno Palanco, Jorge Francisco Gómez Cerezo
Clin Investig Arterioscler. 2023;35:88-90
12
Open Article
11
Nutrition, cardiovascular disease risk and climate change
Carlos A. González Svatetz
Clin Investig Arterioscler. 2023;35:101-3
11
Open Article
11
A step forward in the consensus on lipid profile characteristics for cardiovascular prevention
Xavier Pintó, Juan Pedro-Botet
Clin Investig Arterioscler. 2023;35:85-7
11
Open Article
1
Analysis of the evolocumab (Repatha®) patient support program for patients with cardiovascular disease in Colombia
Ángel Alberto García-Peña, Mariana Pineda-Posada, Carol Páez-Canro, César Cruz, Daniel Samacá-Samacá
Clin Investig Arterioscler. 2023;35:280-9
1
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos